First Human Trial for New Alzheimer’s Vaccine Finds the “Achilles’ Heel” of Alzheimer’s

Rather than targeting amyloid plaques, attacking the Alzheimer's Tau protein induced a positive immune response in 29 of the 30 study volunteers.
The latest research on degenerative cognitive disorders.